Press/Media
- 350 - 375 out of 3,695 results
Search results
-
Study Data from Icahn School of Medicine at Mount Sinai Provide New Insights into Experimental Medicine (Urine Scrnaseq Reveals New Insights Into the Bladder Tumor Immune Microenvironment)
Tran, M., Mehrazin,, R., Sfakianos, J., Sebra, R., Wiklund, P., Horowitz, A., Lin, J. & Bhardwaj, N.
18/07/24
1 item of Media coverage
Press/Media
-
Research from Icahn School of Medicine at Mount Sinai Provide New Insights into COVID-19 (Time-Dependent Effects of Clinical Interventions on SARS-CoV-2 Immunity in Patients with Lung Cancer)
Huang, Y., Hirsch, F., Hirsch, F., Bhalla, S., Krammer, F., Gomez, J., Garcia-Sastre, A., Rodilla, A. & Brody, R.
16/07/24
1 item of Media coverage
Press/Media
-
Trial Establishes Preferred Treatment for Some People With Esophageal Cancer
15/07/24
1 item of Media coverage
Press/Media
-
New Graft-Versus-Host Disease Study Findings Recently Were Reported by Researchers at Emory University (A Validated Risk Strati Fi Cation That Incorporates Magic Biomarkers Predicts Long-term Outcomes In Pediatric Patients With Acute Gvhd)
Srinagesh, H. & Levine, J.
12/07/24
1 item of Media coverage
Press/Media
-
Trial Establishes Preferred Treatment for Some People with Esophageal Cancer
9/07/24
1 item of Media coverage
Press/Media
-
-
-
Researchers from Icahn School of Medicine at Mount Sinai Discuss Findings in Ovarian Cancer (Walking the Tightrope: Fertility Preservation Among Hereditary Breast and Ovarian Cancer Syndrome Previvors)
Blank, S. & Estevez, S.
2/07/24
1 item of Media coverage
Press/Media
-
AECC: The largest Spanish philanthropic project against two of the cancers with the worst prognosis | health and wellness
30/06/24
1 item of Media coverage
Press/Media
-
New Multicenter Study Highlights Use Of The NavDx Test in Resolving Clinically Indeterminate Findings.
28/06/24
1 item of Media coverage
Press/Media
-
-Naveris - New Multicenter Study Highlights Use of the NavDx Test in Resolving Clinically Indeterminate Findings
28/06/24
2 items of Media coverage
Press/Media
-
End-of-Quarter Synopsis Monthly : Regeneron (REGN: $1,051.03) climbs 7%, beating 83% of stocks
28/06/24
1 item of Media coverage
Press/Media
-
New Multicenter Study Highlights Use of the NavDx® Test in Resolving Clinically Indeterminate Findings
27/06/24
7 items of Media coverage
Press/Media
-
New Multicenter Study Highlights Use of the NavDx® Test in Resolving Clinically Indeterminate Findings
27/06/24
1 item of Media coverage
Press/Media
-
IDIBAPS leads an 8-million-euro immunotherapy project granted by the Spanish Association Against Cancer to improve survival in hepatocellular carcinoma
19/06/24
1 item of Media coverage
Press/Media
-
AECC announces the largest financial support for research into low-survival cancers in Spain
19/06/24
1 item of Media coverage
Press/Media
-
Spain's largest philanthropic project against two of the cancers with the worst prognosis
19/06/24
1 item of Media coverage
Press/Media